Walleye Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60,012
| Closed | -$2.31M | – | 3210 |
|
|
2023
Q2 | $2.31M | Sell |
60,012
-334,088
| -85% | -$12.8M | 0.01% | 474 |
|
|
2023
Q1 | $9.12M | Buy |
394,100
+262,725
| +200% | +$6.08M | 0.14% | 152 |
|
|
2022
Q4 | $3.44M | Sell |
131,375
-166,009
| -56% | -$4.35M | 0.06% | 330 |
|
|
2022
Q3 | $5.85M | Buy |
297,384
+20,846
| +8% | +$410K | 0.11% | 188 |
|
|
2022
Q2 | $4.84M | Buy |
276,538
+103,035
| +59% | +$1.8M | 0.13% | 176 |
|
|
2022
Q1 | $2.84M | Sell |
173,503
-3,048
| -2% | -$49.9K | 0.08% | 255 |
|
|
2021
Q4 | $2.88M | Buy |
+176,551
| New | +$2.88M | 0.09% | 239 |
|
|
2021
Q3 | – | Sell |
-16,567
| Closed | -$234 | – | 1869 |
|
|
2021
Q2 | $234 | Buy |
+16,567
| New | +$234 | 0.01% | 1003 |
|
|
2020
Q3 | – | Sell |
-12,852
| Closed | -$148K | – | 1002 |
|
|
2020
Q2 | $148K | Buy |
12,852
+8,652
| +206% | +$99.6K | 0.03% | 471 |
|
|
2020
Q1 | $57K | Buy |
+4,200
| New | +$57K | 0.01% | 417 |
|